Targeting shared immune pathways in multiple sclerosis and type 1 diabetes: Therapeutic insights from monoclonal antibodies.

Pozzilli V, Roma-Wilson M A, Pozzilli C, Buzzetti R

Autoimmun Rev. 2026 Jun 10; 25(9):104121. PMID: 42269843. Abstract